“MediNect Ophtho offers focused preclinical retinal disease research solutions for biotechs, globally. New improved models I Highly collaborative I in vivo I in vitro I retinal disease models I Ophthalmology CRO”
Not loaded yet. See them on Companies House
People and entities with significant control, from the Companies House PSC register
Figures from 2024 accounts. Newer accounts, made up to 31 March 2025, are filed but not read yet. See them on Companies House
| 2024 | 2023 | |
|---|---|---|
| Fixed Assets | £21,867 | £793 |
| Current Assets | £62,761 | £2,340 |
| Creditors (< 1 year) | £66,013 | £11,430 |
| Creditors (> 1 year) | £5,000 | £5,000 |
| Net Current Assets | (£3,252) | (£9,090) |
| Net Assets | £13,615 | (£13,297) |
| Shareholder Funds | £13,615 | (£13,297) |
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 20 January 2026 | Appointment of a director | |||
| 20 January 2026 | Appointment of a director | |||
| 20 January 2026 | Appointment of a director | |||
| 20 January 2026 | Confirmation statement with no updates | 20 January 2026 | ||
| 31 December 2025 | Cessation of a person with significant control |
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →